Form 4 holding
Chief Financial Officer
Quoin Pharmaceuticals, Ltd.
- Security class
- Ordinary Shares
- Shares / value
- 151,077
- Estimated value
- $67,985
- Report date
- 23 Dec 2024
- Price
- $0.4500
- Ownership
- Direct
Gordon Dunn
Insider Reports History
- Reporting-owner location
- Ter Aviv, Israel
- Latest reporting-owner signature
-
/s/ Gordon Dunn
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Gordon Dunn
Form 4 holding
Chief Financial Officer
Quoin Pharmaceuticals, Ltd.
- Security class
- Share Option (Right to Buy)
- Shares / value
- 338,994
- Estimated value
- Report date
- 09 Dec 2024
- Price
- Ownership
- Direct
- Underlying class
- ADS
- Underlying amount
Form 4 holding
Chief Financial Officer
Quoin Pharmaceuticals, Ltd.
- Security class
- Series F Warrants (right to buy)
- Shares / value
- 122,221
- Estimated value
- Report date
- 23 Dec 2024
- Price
- Ownership
- Direct
- Underlying class
- ADS
- Underlying amount
Form 4 holding
Chief Financial Officer
Quoin Pharmaceuticals, Ltd.
- Security class
- Series G Warrants (right to buy)
- Shares / value
- 122,221
- Estimated value
- Report date
- 23 Dec 2024
- Price
- Ownership
- Direct
- Underlying class
- ADS
- Underlying amount
Insider Reports Filed by Gordon Dunn
4
QNRX
Quoin Pharmaceuticals, Ltd.
- Report period
- 23 Dec 2024
- Transactions
- 3
- Transaction value
- +$54,999
- Accepted by SEC
- 27 Dec 2024, 17:16
- Role
- Chief Financial Officer
- Next action
- Open filing details
4
QNRX
Quoin Pharmaceuticals, Ltd.
- Report period
- 09 Dec 2024
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 10 Dec 2024, 16:51
- Role
- Chief Financial Officer
- Next action
- Open filing details
4
QNRX
Quoin Pharmaceuticals, Ltd.
- Report period
- 09 Sep 2024
- Transactions
- 5
- Transaction value
- +$23,205
- Accepted by SEC
- 11 Sep 2024, 16:30
- Role
- Chief Financial Officer
- Next action
- Open filing details
4
QNRX
Quoin Pharmaceuticals, Ltd.
- Report period
- 26 Oct 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 30 Oct 2023, 16:12
- Role
- Chief Financial Officer
- Next action
- Open filing details
3
QNRX
Quoin Pharmaceuticals, Ltd.
- Report period
- 01 Jan 2023
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 03 Jan 2023, 08:40
- Role
- Chief Financial Officer
- Next action
- Open filing details